Naturally plant-derived compounds: Role in bone anabolism

Current Molecular Pharmacology

Volumn 5, Issue 2, 2012, Pages 205-218

  Horcajada, Marie Noëlle ^a   Offord, Elizabeth ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Anabolism; Bone; Flavonoids; Osteoblast; Phytochemicals; Signalling

Indexed keywords

APIGENIN; AURANTIIN; CAJANIN; CATECHIN; CYCLOHEXIMIDE; DAIDZEIN; DRIED PLUM EXTRACT; ELLAGIC ACID; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FORMONONETIN; GALLIC ACID; GALLOCATECHIN; GENISTEIN; HESPERIDIN; ISOFLAVONE DERIVATIVE; KAEMPFEROL; LUTEOLIN; MATAIRESINOL; MYRICETIN; NARIRUTIN; OLEUROPEIN; QUERCETIN; QUERCETIN 3 GLUCURONIDE; RESVERATROL; SECOISOLARICIRESINOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; WALNUT EXTRACT;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BONE DENSITY; BONE METABOLISM; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; CONCENTRATION RESPONSE; DRUG MECHANISM; DRUG POTENCY; GENE EXPRESSION REGULATION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; REVIEW; STRENGTH;

EID: 84861731056     PISSN: 18744672     EISSN: 18744702     Source Type: Journal    
DOI: 10.2174/1874467211205020205     Document Type: Review

References (148)

1. Mundy, G.R. Nutritional modulators of bone remodeling during aging. Am. J. Clin. Nutr., 2006, 83 (2), 427S-430S.
2. Cassidy, A.; Dalais, F.S. Phytochemicals. In Nutrition and Metabolism, Gibney, M. J.; Macdonald, I. A.; Roche, H. M., Eds. Blackwell Publishing: Oxford, 2003; pp. 307-317.
3. Scalbert, A.; Manach, C.; Morand, C.; Remesy, C.; Jimenez, L. Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr., 2005, 45(4), 287-306.
4. New, S.A.; Robins, S.P.; Campbell, M.K.; Martin, J.C.; Garton, M.J.; Bolton-Smith, C.; Grubb, D.A.; Lee, S.J.; Reid, D.M. Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health? Am. J. Clin. Nutr., 2000, 71(1), 142-151.
5. New, S.A.; Millward, D.J. Calcium, protein, and fruit and vegetables as dietary determinants of bone health. Am. J. Clin. Nutr., 2003, 77(5), 1340-1341.
6. Bringhurst, F.R.; Demay, M.B.; Krane, S.M.; Kronenberg, H.M. Bone and mineral metabolism in health and disease. In Harrison's Principles of Internal Medicine, 16 ed.; Kasper, D.L.; Braunwald, E.; Fauci, A.S.; Hauser, S.L.; Longo, D.L.; Jameson, J.L., Eds. Mc Graw-Hill: New York, 2005; pp. 2238-2249.
7. De Vernejoul, M.C.; Marie, P.J. Cellules osseuses et remodelage osseux. MS Med. Sci., 1993, 9(11), 1192-1203.
8. Manolagas, S.C. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev., 2000, 21(2), 115-137.
9. Turner, R.T.; Riggs, B.L.; Spelsberg, T.C. Skeletal effects of estrogen. Endocr. Rev., 1994, 15(3), 275-300.
10. Marie, P.J. Transcription factors controlling osteoblastogenesis. Arch. Biochem. Biophys., 2008, 473(2), 98-105.
11. Komori, T. Regulation of skeletal development by the Runx family of transcription factors. J. Cell. Biochem., 2005, 95(3), 445-453.
12. Celil, A.B.; Hollinger, J.O.; Campbell, P.G. Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling. J. Cell. Biochem., 2005, 95 (3), 518-528.
13. Huang, W.; Yang, S.; Shao, J.; Li, Y. P. Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front. Biosci., 2007, 12, 3068-3092.
14. Yamaguchi, A.; Komori, T.; Suda, T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr. Rev., 2000, 21(4), 393-411.
15. Ducy, P. Cbfa1: a molecular switch in osteoblast biology. Dev. Dyn., 2000, 219(4), 461-471.
16. Nakashima, K.; Zhou, X.; Kunkel, G.; Zhang, Z.P.; Deng, J.M.; Behringer, R.R.; de Crombrugghe, B. The novel zinc fingercontaining transcription factor Osterix is required for osteoblast differentiation and bone formation. Cell, 2002, 108(1), 17-29.
17. Lee, M.H.; Kwon, T.G.; Park, H.S.; Wozney, J.M.; Ryoo, H.M. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem. Biophys. Res. Commun., 2003, 309(3), 689-694.
18. McCabe, L.R.; Kockx, M.; Lian, J.; Stein, J.; Stein, G. Selective expression of fos-and jun-related genes during osteoblast proliferation and differentiation. Exp. Cell Res., 1995, 218(1), 255-62.
19. Fujioka, S.; Niu, J.G.; Schmidt, C.; Sclabas, G.A.; Peng, B.L.; Uwagawa, T.; Li, Z.K.; Evans, D.B.; Abbruzzese, J.L.; Chiao, P.J. NF-KB and AP-1 connection: Mechanism of NF-kappa BDependent regulation of AP-1 activity. Mol. Cell. Biol., 2004, 24(17), 7806-7819.
20. Strewler, G. J. Local and systemic control of the osteoblast. J. Clin. Investig., 2001, 107(3), 271-272.
21. Baylink, D.J.; Finkelman, R.D.; Mohan, S. Growth factors to stimulate bone formation. J. Bone Miner. Res., 1993, 8(Suppl 2), S565-572.
22. Westendorf, J.J.; Kahler, R.A.; Schroeder, T.M. Wnt signaling in osteoblasts and bone diseases. Gene, 2004, 341, 19-39.
23. Kalajzic, I.; Staal, A.; Yang, W.P.; Wu, Y.L.; Johnson, S.E.; Feyen, J.H. M.; Krueger, W.; Maye, P.; Yu, F.; Zhao, Y.F.; Kuo, L.; Gupta, R.R.; Achenie, L.E. K.; Wang, H.W.; Shin, D.G.; Rowe, D.W. Expression profile of osteoblast lineage at defined stages of differentiation. J. Biol. Chem., 2005, 280(26), 24618-24626.
24. Niu, T.H.; Rosen, C.J. The insulin-like growth factor-I gene and osteoporosis: A critical appraisal. Gene, 2005, 361, 38-56.
25. Trzeciakiewicz, A.; Habauzit, V.; Horcajada, M.N. When nutrition interacts with osteoblast function: Molecular mechanisms of polyphenols. Nutr. Res. Rev., 2009, 22(1), 68-81.
26. Canalis, E.; Economides, A.N.; Gazzerro, E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr. Rev., 2003, 24(2), 218-235.
27. Miyazono, K.; Maeda, S.; Imamura, T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling crosstalk. Cytokine Growth Factor Rev., 2005, 16(3), 251-63.
28. Shi, Y.; Massague, J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell, 2003, 113(6), 685-700.
29. Boden, S.D.; Kang, J.; Sandhu, H.; Heller, J.G. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine, 2002, 27(23), 2662-2673.
30. Stein, G.S.; Lian, J.B. Molecular Mechanisms Mediating Proliferation Differentiation Interrelationships During Progressive Development of the Osteoblast Phenotype. Endocr. Rev., 1993, 14(4), 424-442.
31. Ash, P.; Loutit, J.F.; Townsend, K.M. Osteoclasts derived from haematopoietic stem cells. Nature, 1980, 283(5748), 669-670.
32. Felix, R.; Cecchini, M.G.; Fleisch, H. Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology, 1990, 127(5), 2592-2594.
33. Kodama, H.; Yamasaki, A.; Nose, M.; Niida, S.; Ohgame, Y.; Abe, M.; Kumegawa, M.; Suda, T. Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J. Exp. Med., 1991, 173(1), 269-272.
34. Kodama, H.; Nose, M.; Niida, S.; Yamasaki, A. Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J. Exp. Med., 1991, 173(5), 1291-1294.
35. Simonet, W.S.; Lacey, D.L.; Dunstan, C.R.; Kelley, M.; Chang, M.S.; Luthy, R.; Nguyen, H.Q.; Wooden, S.; Bennett, L.; Boone, T.; Shimamoto, G.; DeRose, M.; Elliott, R.; Colombero, A.; Tan, H.L.; Trail, G.; Sullivan, J.; Davy, E.; Bucay, N.; Renshaw-Gegg, L.; Hughes, T.M.; Hill, D.; Pattison, W.; Campbell, P.; Sander, S.; Van, G.; Tarpley, J.; Derby, P.; Lee, R.; Boyle, W. J. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 1997, 89(2), 309-319.
36. Rodan, G.A.; Martin, T.J. Role of osteoblasts in hormonal control of bone resorption--a hypothesis. Calcif. Tissue Int., 1981, 33(4), 349-351.
37. Sambrook, P.; Cooper, C. Osteoporosis. Lancet, 2006, 367(9527), 2010-2018.
38. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Remesy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr., 2005, 81(1), 230S-242S.
39. Khlebnikov, A.I.; Schepetkin, I.A.; Domina, N.G.; Kirpotina, L.N.; Quinn, M.T. Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems. Bioorg. Med. Chem., 2007, 15(4), 1749-1770.
40. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr., 2004, 79(5), 727-47.
41. Kurzer, M.S.; Xu, X. Dietary phytoestrogens. Annu. Rev. Nutr., 1997, 17, 353-381.
42. Setchell, K.D.R.; Brown, N.M.; Lydeking-Olsen, E. The clinical importance of the metabolite equol-A clue to the effectiveness of soy and its isoflavones. J. Nutr., 2002, 132(12), 3577-3584.
43. Pandey, R.; Gautam, A.K.; Bhargavan, B.; Trivedi, R.; Swarnkar, G.; Nagar, G.K.; Yadav, D.K.; Kumar, M.; Rawat, P.; Manickavasagam, L.; Kumar, A.; Maurya, R.; Goel, A.; Jain, G.K.; Chattopadhyay, N.; Singh, D. Total extract and standardized fraction from the stem bark of Butea monosperma have osteoprotective action: Evidence for the nonestrogenic osteogenic effect of the standardized fraction. Menopause, 17(3), 602-610.
44. Habauzit, V.; Horcajada, M.N. Phenolic phytochemicals and bone. Phytochemistry Reviews, 2008, 7(2), 313-344.
45. Anderson, J.J.; Ambrose, W.W.; Garner, S.C. Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc. Soc. Exp. Biol. Med., 1998, 217(3), 345-350.
46. Gao, Y.H.; Yamaguchi, M. Zinc enhancement of genistein's anabolic effect on bone components in elderly female rats. Gen. Pharmacol., 1998, 31(2), 199-202.
47. Ha, H.; Lee, H.Y.; Lee, J.H.; Jung, D.; Choi, J.; Song, K.Y.; Jung, H.J.; Choi, J.S.; Chang, S.I.; Kim, C. Formononetin prevents ovariectomy-induced bone loss in rats. Arch. Pharm. Res., 2012, 33(4), 625-632.
48. Gautam, A.K.; Bhargavan, B.; Tyagi, A.M.; Srivastava, K.; Yadav, D.K.; Kumar, M.; Singh, A.; Mishra, J.S.; Singh, A.B.; Sanyal, S.; Maurya, R.; Manickavasagam, L.; Singh, S.P.; Wahajuddin, W.; Jain, G.K.; Chattopadhyay, N.; Singh, D. Differential effects of formononetin and cladrin on osteoblast function, peak bone mass achievement and bioavailability in rats. J. Nutr. Biochem., 2011, 22(4), 318-327.
49. Bhargavan, B.; Gautam, A.K.; Singh, D.; Kumar, A.; Chaurasia, S.; Tyagi, A.M.; Yadav, D.K.; Mishra, J.S.; Singh, A.B.; Sanyal, S.; Goel, A.; Maurya, R.; Chattopadhyay, N., Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling. J. Cell. Biochem., 2009, 108(2), 388-399.
50. Picherit, C.; Bennetau-Pelissero, C.; Chanteranne, B.; Lebecque, P.; Davicco, M.J.; Barlet, J.P.; Coxam, V. Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J. Nutr., 2001, 131(3), 723-728.
51. Picherit, C.; Horcajada, M.N.; Mathey, J.; Chanteranne, B.; Puel, C.; Lebecque, P.; Davicco, M.J.; Coxam, V.; Barlet, J.P. Isoflavone consumption does not increase the bone mass in osteopenic obese female zucker rats. Ann. Nutr. Metab., 2003, 47(2), 70-77.
52. Breitman, P.L.; Fonseca, D.; Cheung, A.M.; Ward, W.E. Isoflavones with supplemental calcium provide greater protection against the loss of bone mass and strength after ovariectomy compared to isoflavones alone. Bone, 2003, 33(4), 597-605.
53. Fonseca, D.; Ward, W.E. Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice. Bone, 2004, 35(2), 489-497.
54. Bahr, J.M.; Nakai, M.; Rivera, A.; Walsh, J.; Evans, G.L.; Lotinun, S.; Turner, R.T.; Black, M.; Jeffery, E.H. Dietary soy protein and isoflavones: minimal beneficial effects on bone and no effect on the reproductive tract of sexually mature ovariectomized Sprague-Dawley rats. Menopause, 2005, 12(2), 165-173.
55. Ishimi, Y.; Yoshida, M.; Wakimoto, S.; Wu, J.; Chiba, H.; Wang, X.; Takeda, K.; Miyaura, C. Genistein, a soybean isoflavone, affects bone marrow lymphopoiesis and prevents bone loss in castrated male mice. Bone, 2002, 31(1), 180-185.
56. Wu, J.; Wang, X.X.; Chiba, H.; Higuchi, M.; Takasaki, M.; Ohta, A.; Ishimi, Y. Combined intervention of exercise and genistein prevented androgen deficiency-induced bone loss in mice. J. Appl. Physiol., 2003, 94(1), 335-342.
57. Khalil, D.A.; Lucas, E.A.; Smith, B.J.; Soung, D.Y.; Devareddy, L.; Juma, S.; Akhter, M.P.; Recker, R.; Arjmandi, B.H. Soy isoflavones may protect against orchidectomy-induced bone loss in aged male rats. Calcif. Tissue Int., 2005, 76(1), 56-62.
58. Soung, D.Y.; Devareddy, L.; Khalil, D.A.; Hooshmand, S.; Patade, A.; Lucas, E.A.; Arjmandi, B. H. Soy affects trabecular microarchitecture and favorably alters select bone-specific gene expressions in a male rat model of osteoporosis. Calcif. Tissue Int., 2006, 78(6), 385-391.
59. Setchell, K.D.R.; Clerici, C. Equol: History, chemistry, and formation. J. Nutr., 140(7), 1355S-1362S.
60. Chen, X.W.; Garner, S.C.; Anderson, J.J. Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. Biochem. Biophys. Res. Commun., 2002, 295(2), 417-422.
61. De Wilde, A.; Lieberherr, M.; Colin, C.; Pointillart, A. A low dose of daidzein acts as an ERbeta-selective agonist in trabecular osteoblasts of young female piglets. J. Cell. Physiol. 2004, 200(2), 253-262.
62. Yamaguchi, M. Isoflavone and bone metabolism: Its cellular mechanism and preventive role in bone loss. J. Health Sci., 2002, 48(3), 209-222.
63. Yamaguchi, M.; Gao, Y.H. Anabolic effect of genistein on bone metabolism in the femoral-metaphyseal tissues of elderly rats is inhibited by the anti-estrogen tamoxifen. Res. Exp. Med.(Berl), 1997, 197(2), 101-107.
64. Gao, Y.H.; Yamaguchi, M. Anabolic effect of daidzein on cortical bone in tissue culture: comparison with genistein effect. Mol. Cell. Biochem., 1999, 194(1-2), 93-97.
65. Sugimoto, E.; Yamaguchi, M., Anabolic effect of genistein in osteoblastic MC3T3-E1 cells. Int. J. Mol. Med., 2000, 5(5), 515-520.
66. Sugimoto, E.; Yamaguchi, M. Stimulatory effect of Daidzein in osteoblastic MC3T3-E1 cells. Biochem. Pharmacol., 2000, 59(5), 471-475.
67. Yamaguchi, M.; Sugimoto, E. Stimulatory effect of genistein and daidzein on protein synthesis in osteoblastic MC3T3-E1 cells: activation of aminoacyl-tRNA synthetase. Mol. Cell. Biochem., 2000, 214 (1-2), 97-102.
68. Kanno, S.; Hirano, S.; Kayama, F. Effects of phytoestrogens and environmental estrogens on osteoblastic differentiation in MC3T3-E1 cells. Toxicology, 2004, 196(1-2), 137-145.
69. Ge, Y.B.; Chen, D.W.; Xie, L.P.; Zhang, R.Q. Enhancing effect of daidzein on the differentiation and mineralization in mouse osteoblast-like MC3T3-E1 cells. Yakugaku Zasshi, 2006, 126(8), 651-656.
70. Chang, H.; Jin, T.Y.; Jin, W.F.; Gu, S.Z.; Zhou, Y.F. Modulation of isoflavones on bone-nodule formation in rat calvaria osteoblasts in vitro. Biomed. Environ. Sci., 2003, 16(1), 83-89.
71. Suh, K.S.; Koh, G.; Park, C.Y.; Woo, J.T.; Kim, S.W.; Kim, J.W.; Park, I.K.; Kim, Y.S. Soybean isoflavones inhibit tumor necrosis factor-alpha-induced apoptosis and the production of interleukin-6 and prostaglandin E2 in osteoblastic cells. Phytochemistry, 2003, 63(2), 209-215.
72. Viereck, V.; Grundker, C.; Blaschke, S.; Siggelkow, H.; Emons, G.; Hofbauer, L.C. Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts. J. Cell. Biochem., 2002, 84(4), 725-735.
73. Jia, T.L.; Wang, H.Z.; Xie, L.P.; Wang, X.Y.; Zhang, R.Q. Daidzein enhances osteoblast growth that may be mediated by increased bone morphogenetic protein (BMP) production. Biochem. Pharmacol., 2003, 65(5), 709-715.
74. oB activity. Int. J. Mol., Med., 2009, 23(2), 297-301.
75. Wang, L.Q. Mammalian phytoestrogens: enterodiol and enterolactone. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 2002, 777(1-2), 289-309.
76. Horcajada-Molteni, M.N.; Davicco, M.J.; Lebecque, P.; Coxam, V.; Miller, S.C.; Remesy, C.; Barlet, J.P. Effect of lignans on ovariectomy-induced bone loss in rats. J. Bone Miner. Res., 2000, (suppl. 15), S553.
77. Power, K.A.; Ward, W.E.; Chen, J.M.; Saarinen, N.M.; Thompson, L.U. Genistein alone and in combination with the mammalian lignans enterolactone and enterodiol induce estrogenic effects on bone and uterus in a postmenopausal breast cancer mouse model. Bone, 2006, 39(1), 117-124.
78. Ward, W.E.; Yuan, Y.V.; Cheung, A.M.; Thompson, L.U. Exposure to purified lignan from flaxseed (Linum usitatissimum) alters bone development in female rats. Br. J. Nutr., 2001, 86(4), 499-505.
79. Lee, M.K.; Yang, H.; Ma, C.J.; Kim, Y.C. Stimulatory activity of lignans from Machilus thunbergii on osteoblast differentiation. Biol. Pharm. Bull., 2007, 30(4), 814-817.
80. Delaisse, J.M.; Eeckhout, Y.; Vaes, G. Inhibition of bone resorption in culture by (+)-catechin. Biochem. Pharmacol., 1986, 35(18), 3091-3094.
81. Choi, E.M.; Hwang, J.K. Effects of (+)-catechin on the function of osteoblastic cells. Biol. Pharm. Bull., 2003, 26(4), 523-526.
82. Johnell, O.; Gullberg, B.; Kanis, J.A.; Allander, E.; Elffors, L.; Dequeker, J.; Dilsen, G.; Gennari, C.; Lopes Vaz, A.; Lyritis, G.;. Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J. Bone Miner. Res., 1995, 10(11), 1802-1815.
83. Kanis, J.; Johnell, O.; Gullberg, B.; Allander, E.; Elffors, L.; Ranstam, J.; Dequeker, J.; Dilsen, G.; Gennari, C.; Vaz, A.L.; Lyritis, G.; Mazzuoli, G.; Miravet, L.; Passeri, M.; Perez Cano, R.; Rapado, A.; Ribot, C. Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos. Int., 1999, 9(1), 45-54.
84. Hegarty, V.M.; May, H.M.; Khaw, K.T. Tea drinking and bone mineral density in older women. Am. J. Clin. Nutr., 2000, 71(4), 1003-1007.
85. McKay, D.L.; Blumberg, J.B. The role of tea in human health: An update. J. Am. Coll. Nutr., 2002, 21(1), 1-13.
86. Nakagawa, H.; Wachi, M.; Woo, J.T.; Kato, M.; Kasai, S.; Takahashi, F.; Lee, I.S.; Nagai, K. Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochem. Biophys. Res. Commun., 2002, 292(1), 94-101.
87. Mizutani, A.; Sugiyama, I.; Kuno, E.; Matsunaga, S.; Tsukagoshi, N. Expression of matrix metalloproteinases during ascorbateinduced differentiation of osteoblastic MC3T3-E1 cells. J. Bone Miner. Res., 2001, 16(11), 2043-2049.
88. Chen, C.H.; Ho, M.L.; Chang, J.K.; Hung, S.H.; Wang, G.J. Green tea catechin enhances osteogenesis in a bone marrow mesenchymal stem cell line. Osteoporos. Int., 2005, 16(12), 2039-2045.
89. Vali, B.; Rao, L.G.; El-Sohemy, A. Epigallocatechin-3-gallate increases the formation of mineralized bone nodules by human osteoblast-like cells. J. Nutr. Biochem., 2007, 18(5), 341-347.
90. Tokuda, H.; Takai, S.; Matsushima-Nishiwaki, R.; Akamatsu, S.; Hanai, Y.; Hosoi, T.; Harada, A.; Ohta, T.; Kozawa, O. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts. J. Cell. Biochem., 2007, 100(5), 1146-1153.
91. Ko, C.H.; Lau, K.M.; Choy, W.Y.; Leung, P.C. Effects of tea catechins, epigallocatechin, gallocatechin, and gallocatechin gallate, on bone metabolism. J. Agric. Food Chem., 2009, 57(16), 7293-7297.
92. Tang, G.Q.; Yan, T.Q.; Guo, W.; Ren, T.T.; Peng, C.L.; Zhao, H.; Lu, X.C.; Zhao, F.L.; Han, X. Epigallocatechin-3-gallate induces apoptosis and suppresses proliferation by inhibiting the human Indian Hedgehog pathway in human chondrosarcoma cells. J. Cancer Res. Clin. Oncol., 136(8), 1179-1185.
93. Liao, S.; Kao, Y.H.; Hiipakka, R.A. Green tea: biochemical and biological basis for health benefits. Vitam. Horm., 2001, 62, 1-94.
94. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr., 2004, 79(5), 727-747.
95. Hollman, P.C.H.; Arts, I.C. W. Flavonols, flavones and flavanols-nature, occurrence and dietary burden. J. Sci. Food Agr., 2000, 80(7), 1081-1093.
96. Horcajada-Molteni, M.N.; Crespy, V.; Coxam, V.; Davicco, M.J.; Remesy, C.; Barlet, J.P. Rutin inhibits ovariectomy-induced osteopenia in rats. J. Bone Miner. Res., 2000, 15(11), 2251-2258.
97. Tsuji, M.; Yamamoto, H.; Sato, T.; Mizuha, Y.; Kawai, Y.; Taketani, Y.; Kato, S.; Terao, J.; Inakuma, T.; Takeda, E. Dietary quercetin inhibits bone loss without effect on the uterus in ovariectomized mice. J. Bone Miner. Metab., 2009, 27(6), 673-681.
98. Trivedi, R.; Kumar, S.; Kumar, A.; Siddiqui, J.A.; Swarnkar, G.; Gupta, V.; Kendurker, A.; Dwivedi, A.K.; Romero, J.R.; Chattopadhyay, N. Kaempferol has osteogenic effect in ovariectomized adult Sprague-Dawley rats. Mol. Cell. Endocrinol., 2008, 289(1-2), 85-93.
99. Wattel, A.; Kamel, S.; Mentaverri, R.; Lorget, F.; Prouillet, C.; Petit, J. P.; Fardelonne, P.; Brazier, M. Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption. Biochem. Pharmacol., 2003, 65(1), 35-42.
100. Wattel, A.; Kamel, S.; Prouillet, C.; Petit, J.P.; Lorget, F.; Offord, E.; Brazier, M. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1. J. Cell. Biochem., 2004, 92(2), 285-295.
101. Pang, J.L.; Ricupero, D.A.; Huang, S.; Fatma, N.; Singh, D.P.; Romero, J.R.; Chattopadhyay, N. Differential activity of kaempferol and quercetin in attenuating tumor necrosis factor receptor family signaling in bone cells. Biochem. Pharmacol., 2006, 71(6), 818-826.
102. Son, Y.O.; Kook, S.H.; Choi, K.C.; Jang, Y.S.; Choi, Y.S.; Jeon, Y.M.; Kim, J.G.; Hwang, H.S.; Lee, J.C. Quercetin accelerates TNF-alpha-induced apoptosis of MC3T3-E1 osteoblastic cells through caspase-dependent and JNK-mediated pathways. Eur. J. Pharmacol., 2008, 579(1-3), 26-33.
103. Notoya, M.; Tsukamoto, Y.; Nishimura, H.; Woo, J.T.; Nagai, K.; Lee, I.S.; Hagiwara, H. Quercetin, a flavonoid, inhibits the proliferation, differentiation, and mineralization of osteoblasts in vitro. Eur. J. Pharmacol., 2004, 485(1-3), 89-96.
104. Prouillet, C.; Maziere, J.C.; Maziere, C.; Wattel, A.; Brazier, M.; Kamel, S. Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem. Pharmacol.,2004, 67(7), 1307-1313.
105. Kim, Y.J.; Bae, Y.C.; Suh, K.T.; Jung, J.S. Quercetin, a flavonoid, inhibits proliferation and increases osteogenic differentiation in human adipose stromal cells. Biochem. Pharmacol., 2006, 72(10), 1268-1278.
106. Kim, D.S.; Takai, H.; Arai, M.; Araki, S.; Mezawa, M.; Kawai, Y.; Murota, K.; Terao, J.; Ogata, Y. Effects of quercetin and quercetin 3-glucuronide on the expression of bone sialoprotein gene. J. Cell. Biochem.,2007 101(3), 790-800.
107. Miyake, M.; Arai, N.; Ushio, S.; Iwaki, K.; Ikeda, M.; Kurimoto, M. Promoting effect of kaempferol on the differentiation and mineralization of murine pre-osteoblastic cell line MC3T3-E1. Biosci. Biotechnol. Biochem., 2003, 67(6), 1199-1205.
108. Tomas-Barberan, F.A.; Clifford, M.N. Flavanones, chalcones and dihydrochalcones-nature, occurrence and dietary burden. J. Sci. Food Agr., 2000, 80(7), 1073-1080.
109. Manach, C.; Morand, C.; Gil-Izquierdo, A.; Bouteloup-Demange, C.; Remesy, C. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur. J. Clin. Nutr., 2003, 57(2), 235-242.
110. Muhlbauer, R.C.; Lozano, A.; Reinli, A.; Wetli, H. Various selected vegetables, fruits, mushrooms and red wine residue inhibit bone resorption in rats. J. Nutr., 2003, 133(11), 3592-3597.
111. Chiba, H.; Uehara, M.; Wu, J.; Wang, X.X.; Masuyama, R.; Suzuki, K.; Kanazawa, K.; Ishimi, Y. Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J. Nutr., 2003, 133(6), 1892-1897.
112. Horcajada, M.; Coxam, V. Hesperidin, a citrus flavanone, improves bone acquisition and prevents skeletal impairment in rats. In Nutritional aspects of osteoporosis. Eds: P. Burckardt, B. Dawson-Hughes, RP. Heaney., 2004; pp. 103-120.
113. Habauzit, V.; Nielsen, I.L.; Gil-Izquierdo, A.; Trzeciakiewicz, A.; Morand, C.; Chee, W.; Barron, D.; Lebecque, P.; Davicco, M.J.; Williamson, G.; Offord, E.; Coxam, V.; Horcajada, M.N. Increased bioavailability of hesperetin-7-glucoside compared with hesperidin results in more efficient prevention of bone loss in adult ovariectomised rats. Br. J. Nutr., 2009, 102(7), 976-984.
114. Deyhim, F.; Garica, K.; Lopez, E.; Gonzalez, J.; Ino, S.; Garcia, M.; Patil, B.S. Citrus juice modulates bone strength in male senescent rat model of osteoporosis. Nutrition, 2006, 22(5), 559-563.
115. Trzeciakiewicz, A.; Habauzit, V.; Mercier, S.; Barron, D.; Urpi-Sarda, M.; Manach, C.; Offord, E.; Horcajada, M.N. Molecular mechanism of hesperetin-7-O-glucuronide, the main circulating metabolite of hesperidin, involved in osteoblast differentiation. J. Agric. Food Chem.,58(1), 668-675.
116. Trzeciakiewicz, A.; Habauzit, V.; Mercier, S.; Lebecque, P.; Davicco, M.J.; Coxam, V.; Demigne, C.; Horcajada, M.N. Hesperetin stimulates differentiation of primary rat osteoblasts involving the BMP signalling pathway. J. Nutr. Biochem., 21(5), 424-431.
117. Wong, R. W.K.; Rabie, A.B.M. Effect of naringin collagen graft on bone formation. Biomaterials, 2006, 27(9), 1824-1831.
118. Wong, R.W.K.; Rabie, A.B.M. Effect of naringin on bone cells. J. Orthop. Res., 2006, 24(11), 2045-2050.
119. Park, J.A.; Ha, S.K.; Kang, T.H.; Oh, M.S.; Cho, M.H.; Lee, S.Y.; Park, J.H.; Kim, S.Y. Protective effect of apigenin on ovariectomyinduced bone loss in rats. Life Sci., 2008, 82(25-26), 1217-1223.
120. Bandyopadhyay, S.; Lion, J.M.; Mentaverri, R.; Ricupero, D.A.; Kamel, S.; Romero, J.R.; Chattopadhyay, N. Attenuation of osteoclastogenesis and osteoclast function by apigenin. Biochem. Pharmacol., 2006, 72(2), 184-197.
121. Choi, E.M. Apigenin increases osteoblastic differentiation and inhibits tumor necrosis factor-α-induced production of interleukin-6 and nitric oxide in osteoblastic MC3T3-E1 cells. Pharmazie, 2007, 62(3), 216-220.
122. Gu, X.; Creasy, L.; Kester, A.; Zeece, M. Capillary electrophoretic determination of resveratrol in wines. J. Agric. Food Chem., 1999, 47(8), 3223-3227.
123. King, R.E.; Bomser, J.A.; Min, D.B. Bioactivity of resveratrol. Compr. Rev. Food Sci. Food Saf. 2006, 5(3), 65-70.
124. Mizutani, K.; Ikeda, K.; Kawai, Y.; Yamori, Y. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem. Biophys. Res. Commun., 1998, 253(3), 859-863.
125. Dai, Z.; Li, Y.; Quarles, L.D.; Song, T.; Pan, W.; Zhou, H.; Xiao, Z. Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation. Phytomedicine, 2007, 14(12), 806-814.
126. Boissy, P.; Andersen, T.L.; Abdallah, B.M.; Kassem, M.; Plesner, T.; Delaisse, J.M. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Res., 2005, 65(21), 9943-9952.
127. Rucinski, M.; Ziolkowska, A.; Hochol, A.; Pucher, A.; Macchi, C.; Belloni, A.S.; Nussdorfer, G.G.; Malendowicz, L.K. Estradiol and resveratrol stimulating effect on osteocalcin, but not osteonectin and collagen-1alpha gene expression in primary culture of rat calvarial osteoblast-like cells. Int. J. Mol. Med., 2006, 18(4), 565-570.
128. Chang, J.K.; Hsu, Y.L.; Teng, I.C.; Kuo, P.L. Piceatannol stimulates osteoblast differentiation that may be mediated by increased bone morphogenetic protein-2 production. Eur. J. Pharmacol., 2006, 551(1-3), 1-9.
129. de la Puerta, R.; Ruiz Gutierrez, V.; Hoult, J.R. Inhibition of leukocyte 5-lipoxygenase by phenolics from virgin olive oil. Biochem. Pharmacol., 1999, 57(4), 445-449.
130. Puel, C.; Mathey, J.; Agalias, A.; Kati-Coulibaly, S.; Mardon, J.; Obled, C.; Davicco, M.J.; Lebecque, P.; Horcajada, M.N.; Skaltsounis, A.L.; Coxam, V. Dose-response study of effect of oleuropein, an olive oil polyphenol, in an ovariectomy/inflammation experimental model of bone loss in the rat. Clin. Nutr., 2006, 25(5), 859-868.
131. Puel, C.; Quintin, A.; Agalias, A.; Mathey, J.; Obled, C.; Mazur, A.; Davicco, M. J.; Lebecque, P.; Skaltsounis, A.L.; Coxam, V. Olive oil and its main phenolic micronutrient (oleuropein) prevent inflammation-induced bone loss in the ovariectomised rat. Br. J. Nutr., 2004, 92(1), 119-127.
132. Santiago-Mora, R.; Casado-DÃ-az, A.; De Castro, M.D.; Quesada-GÃmez, J.M. Oleuropein enhances osteoblastogenesis and inhibits adipogenesis: the effect on differentiation in stem cells derived from bone marrow. Osteoporos. Int., 2011, 22(2), 675-684.
133. Deyhim, F.; Stoecker, B.J.; Brusewitz, G.H.; Devareddy, L.; Arjmandi, B.H. Dried plum reverses bone loss in an osteopenic rat model of osteoporosis. Menopause, 2005, 12(6), 755-762.
134. Franklin, M.; Bu, S.Y.; Lerner, M.R.; Lancaster, E.A.; Bellmer, D.; Marlow, D.; Lightfoot, S.A.; Arjmandi, B.H.; Brackett, D.J.; Lucas, E.A.; Smith, B.J. Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway. Bone, 2006, 39(6), 1331-1342.
135. Bu, S.; Lucas, E.; Franklin, M.; Marlow, D.; Brackett, D.; Boldrin, E.; Devareddy, L.; Arjmandi, B.; Smith, B. Comparison of dried plum supplementation and intermittent PTH in restoring bone in osteopenic orchidectomized rats. Osteoporos. Int., 2007, 18(7), 931-942.
136. Bu, S.Y.; Hunt, T.S.; Smith, B.J. Dried plum polyphenols attenuate the detrimental effects of TNF-alpha on osteoblast function coincident with up-regulation of Runx2, Osterix and IGF-I. J. Nutr. Biochem., 2009, 20(1), 35-44.
137. Colaric, M.; Veberic, R.; Solar, A.; Hudina, M.; Stampar, F. Phenolic acids, syringaldehyde, and juglone in fruits of different cultivars of Juglans regia L. J. Agric. Food Chem., 2005, 53(16), 6390-6396.
138. Papoutsi, Z.; Kassi, E.; Chinou, I.; Halabalaki, M.; Skaltsounis, L.A.; Moutsatsou, P. Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. Br. J. Nutr.,2008, 99(4), 715-722.
139. Papoutsi, Z.; Kassi, E.; Tsiapara, A.; Fokialakis, N.; Chrousos, G.P.; Moutsatsou, P. Evaluation of estrogenic/antiestrogenic activity of ellagic acid via the estrogen receptor subtypes ER alpha and ER beta. J. Agric. Food Chem., 2005, 53(20), 7715-7720.
140. Park, C.K.; Ishimi, Y.; Ohmura, M.; Yamaguchi, M.; Ikegami, S. Vitamin A and carotenoids stimulate differentiation of mouse osteoblastic cells. J. Nutr. Sci. Vitaminol. (Tokyo), 1997, 43(3), 281-296.
141. Nagasawa, H.; Takahashi, S.; Kobayashi, A.; Tazawa, H.; Tashima, Y.; Sato, K. Effect of retinoic acid on murine preosteoblastic MC3T3-E1 cells. J. Nutr. Sci. Vitaminol. (Tokyo) 2005, 51(5), 311-8.
142. Kim, L.; Rao, A.V.; Rao, L.G. Lycopene II--effect on osteoblasts: the carotenoid lycopene stimulates cell proliferation and alkaline phosphatase activity of SaOS-2 cells. J. Med. Food, 2003, 6(2), 79-86.
143. Uchiyama, S.; Yamaguchi, M. beta-Cryptoxanthin stimulates cell proliferation and transcriptional activity in osteoblastic MC3T3-E1 cells. Int. J. Mol. Med., 2005, 15(4), 675-81.
144. Uchiyama, S.; Yamaguchi, M. beta-cryptoxanthin stimulates cell differentiation and mineralization in osteoblastic MC3T3-E1 cells. J. Cell. Biochem., 2005, 95(6), 1224-34.
145. Uchiyama, S.; Yamaguchi, M. Anabolic effect of betacryptoxanthin in osteoblastic MC3T3-E1 cells is enhanced with 17beta-estradiol, genistein, or zinc sulfate in vitro: the unique effect with zinc on Runx2 and alpha1(I) collagen mRNA expressions. Mol. Cell. Biochem., 2008, 307(1-2), 209-219.
146. oB activation in MC3T3 preosteoblasts. Mol. Med. Report., 2009, 2(4), 641-644.
147. Uchiyama, S.; Yamaguchi, M. Oral administration of betacryptoxanthin prevents bone loss in ovariectomized rats. Int. J. Mol. Med., 2006, 17(1), 15-20.
148. Yang, X.Z.; Ji, C.J.; Chen, X.L.; Li, L. Effect of lycopene on bone mass and biomechanics in ovariectomized rats. Journal of Clinical Rehabilitative Tissue Engineering Research 2008, 12 (15), 2811-2814.